-
New anode of potassium ion battery: hollow carbon material grafted with sulfur
Time of Update: 2019-06-25
As the most successful commercial ion battery at present, the lithium-ion battery with high energy storage density, convenient carrying and long service life has penetrated into all aspects of human l
-
LVYE pharmaceutical released its performance in the first half of 2018: core products achieved double-digit growth, sales, R & D and M & a performance exceeded expectations
Time of Update: 2018-08-28
August 27, 2018 / Meitong news agency / -- green leaf Pharmaceutical Group (02186 HK) issued the performance announcement for the first half of 2018 on August 26 The financial report shows that the co
-
Oncology letters: the combination of soy lecithin and NSAIDs can prevent cancer and have less side effects
Time of Update: 2018-05-31
May 31, 2018 / bioin / - when scientists at the University of Texas Health Medical Center (uthealth) applied soy lecithin with a non steroidal anti-inflammatory drug (NSAID), they found that its antic
-
Nash lost another point, galectin shares fell 30
Time of Update: 2017-12-06
Source: U.S - China drug source December 6, 2017 [news event]: today, the Nash drug and galectin inhibitor gr-md-02 of galectin therapeutics, a biotechnology company, failed to reach the primary end p
-
Biomedical industry should build technical barriers into moats
Time of Update: 2017-08-14
According to the data from the National Bureau of statistics, in the first half of 2017, China's pharmaceutical manufacturing industry achieved an operating revenue of 1463.67 billion yuan, an increas
-
Weigh! The first domestic preparation for export was transferred to domestic product "azithromycin for injection" and approved for listing
Time of Update: 2017-08-08
Source: Pharmaceutical magic cube 2017-08-08 Hainan Puli pharmaceutical announced on August 7 that azithromycin for injection of the company recently obtained the drug registration approval (approval
-
Drug regulation of norepinephrine may be able to treat obsessive-compulsive disorder
Time of Update: 2017-06-06
Obsessive-compulsive disorder, commonly known as "obsessive-compulsive disorder", is a kind of mental disorder which is common in clinic but difficult to cure ERP is the most effective treatment for o
-
Direct activation of a tumor suppressor protein by a new small molecule can prevent the growth of lung cancer
Time of Update: 2017-05-18
In a new study, researchers found that using a new small molecule to directly activate a tumor suppressor protein can prevent the growth of lung cancer in mice Dr goutham narla, of Case Western Reserv
-
The three-stage clinical effect of targeted drugs for Roche lung cancer is better than that of chemotherapy
Time of Update: 2017-04-14
Source: Roche, a famous pharmaceutical company of sina pharmaceutical, announced today that its phase 3 clinical trial Alur reached the main clinical end point, confirming that compared with chemother
-
Multinational pharmaceutical companies' different performance in Chinese market in 2016q3: four reasons
Time of Update: 2016-12-06
Source: China's cube data official account 2016-12-6 the multinational pharmaceutical enterprises in the third quarter of this year showed relatively stable performance in China, and remained at a low
-
GlaxoSmithKline divested its narcotics business for $370 million
Time of Update: 2016-09-13
Source: DXY 2016-09-13 GlaxoSmithKline plans to sell its narcotic drug portfolio to Aspen pharmaceuticals in South Africa for us $370 million, which is part of its drive to focus on core treatment are
-
The government actively encourages the global generic drug market to have a promising future
Time of Update: 2016-06-24
Source: on June 24, 2016, due to the aging of the global population and the increasingly expensive price of new drugs, medical expenditure became increasingly heavy Many governments began to actively
-
Disclosure of decisive factors in the time of FDA new drug review
Time of Update: 2015-10-28
Source: from October 28, 2015, the Manhattan Institute released a research report on the efficiency evaluation of FDA new drug approval in April 2014, which was called Center for drug evaluation and Research (CDER) ）There are some differences in the time of new drug review between different drug approval departments, so they think that some departments are more "productive" than others So is the conclusion of this study Tenable?
-
Pfizer and Merck will jointly sell the lung cancer drug clozatinib
Time of Update: 2015-04-10
Source: Ding Xiangyuan, April 10, 2015, Pfizer and Merck, Germany, recently announced a deal between the two companies According to the deal, the two companies will jointly market Pfizer's lung cancer
-
The national medical insurance catalog is in the industry: more than 80% of the drug prices are down
Time of Update: 2015-03-13
Source: Economic Reference News 2015-03-13 drug price reform linked to the adjustment of medical insurance payment method, the reporter of economic reference news recently learned from the authority t
